STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
AcquisitionMar 30, 2026, 03:35 AM

Abbott to Acquire Exact Sciences for $105 per Share in Cash

AI Summary

Abbott Laboratories has entered into a definitive agreement to acquire Exact Sciences Corporation for $105.00 per share in cash. The acquisition will make Exact Sciences a wholly-owned subsidiary of Abbott and is subject to customary closing conditions, including regulatory approvals and approval by Exact Sciences shareholders.

Key Highlights

  • Abbott will acquire Exact Sciences for $105 per share in cash.
  • The transaction is subject to customary closing conditions, including regulatory approvals and shareholder approval.
  • Exact Sciences will become a wholly-owned subsidiary of Abbott upon completion of the merger.
ABT
Biotechnology: Pharmaceutical Preparations
ABBOTT LABORATORIES

Price Impact